These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 480011

  • 1. The use of plasma androstenedione in monitoring therapy of patients with congenital adrenal hyperplasia.
    Cavallo A, Corn C, Bryan GT, Meyer WJ.
    J Pediatr; 1979 Jul; 95(1):33-7. PubMed ID: 480011
    [Abstract] [Full Text] [Related]

  • 2. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
    Lee PA, Urban MD, Gutai JP, Migeon CJ.
    Horm Res; 1980 Jul; 13(6):347-57. PubMed ID: 7196877
    [Abstract] [Full Text] [Related]

  • 3. Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression.
    Keenan BS, McNeel R, Barrett GN, Holcombe JH, Kirkland RT, Clayton GW.
    J Lab Clin Med; 1979 Nov; 94(5):799-808. PubMed ID: 159330
    [No Abstract] [Full Text] [Related]

  • 4. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE, Sizonenko PC.
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [Abstract] [Full Text] [Related]

  • 5. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
    Linder B, Feuillan P, Chrousos GP.
    J Clin Endocrinol Metab; 1989 Jul; 69(1):191-5. PubMed ID: 2543690
    [Abstract] [Full Text] [Related]

  • 6. Urinary and serum steroid concentrations in the management of congenital adrenal hyperplasia. Lack of physiologic correlations.
    Hendricks SA, Lippe BM, Kaplan SA, Lavin N, Mayes DM.
    Am J Dis Child; 1982 Mar; 136(3):229-32. PubMed ID: 7064949
    [Abstract] [Full Text] [Related]

  • 7. Plasma 3 alpha-androstanediol glucuronide in normal children and in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Lopes LA, Catzeflis C, Cicotti I, Rey C, Sizonenko PC.
    Horm Res; 1997 Mar; 48(1):35-40. PubMed ID: 9195208
    [Abstract] [Full Text] [Related]

  • 8. 17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.
    von Schnakenburg K, Bidlingmaier F, Knorr D.
    Eur J Pediatr; 1980 May; 133(3):259-67. PubMed ID: 7389739
    [Abstract] [Full Text] [Related]

  • 9. Inappropriate adrenal androgen secretion with once-a-day corticosteroid therapy for congenital adrenal hyperplasia.
    Keenan BS, Eberle AE, Lin TH, Clayton GW.
    J Pediatr; 1990 Jan; 116(1):133-6. PubMed ID: 2153199
    [Abstract] [Full Text] [Related]

  • 10. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
    Sulcová J, Lisá L, Dvorák P, Hampl R, Stárka L.
    Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
    [Abstract] [Full Text] [Related]

  • 11. Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.
    Hansen JW, Loriaux DL.
    Pediatrics; 1976 Jun; 57(6):942-7. PubMed ID: 934750
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
    Juniarto AZ, Goossens K, Setyawati BA, Drop SL, de Jong FH, Faradz SM.
    Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
    [Abstract] [Full Text] [Related]

  • 16. Treatment of congenital virilizing adrenal hyperplasia patients with single and multiple daily doses of prednisone.
    Huseman CA, Varma MM, Blizzard RM, Johanson A.
    J Pediatr; 1977 Apr; 90(4):538-42. PubMed ID: 839364
    [Abstract] [Full Text] [Related]

  • 17. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
    Horm Res; 1997 Apr; 47(1):17-22. PubMed ID: 9010713
    [Abstract] [Full Text] [Related]

  • 18. Androstenedione and its conversion to plasma testosterone in congenital adrenal hyperplasia.
    Horton R, Frasier SD.
    J Clin Invest; 1967 Jun; 46(6):1003-9. PubMed ID: 4290686
    [Abstract] [Full Text] [Related]

  • 19. Hormonal and clinical responses to prednisone treatment in adolescents with congenital adrenal hyperplasia.
    Zipf WB, Bacon GE, Kelch RP.
    Horm Res; 1980 Jun; 12(4):206-17. PubMed ID: 6446517
    [Abstract] [Full Text] [Related]

  • 20. Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia.
    Korth-Schutz S, Virdis R, Saenger P, Chow DM, Levine LS, New MI.
    J Clin Endocrinol Metab; 1978 Mar; 46(3):452-8. PubMed ID: 156192
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.